Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection

• Published in: Transplantation Vol. 93; no. 1; p. 24
• Main Authors: Kakuta, Yoichi, Okumi, Masayoshi, Miyagawa, Shuji, Tsutahara, Koichi, Abe, Toyofumi, Yazawa, Koji, Matsunami, Katsuyoshi, Otsuka, Hideaki, Takahara, Shiro, Nonomura, Norio
• Format: Journal Article
• Language: English
• Published: United States 15.01.2012
• Subjects: Amides - pharmacology; Animals; CCR5 Receptor Antagonists; Cell Movement - physiology; Chemokines - metabolism; Cyclosporine - therapeutic use; Cytokines - metabolism; Graft Rejection - pathology; Graft Rejection - physiopathology; Graft Rejection - prevention & control; Graft Survival - drug effects; Immunosuppressive Agents - therapeutic use; Kidney Transplantation - immunology; Kidney Transplantation - pathology; Macrophages - physiology; Male; Models, Animal; Quaternary Ammonium Compounds - pharmacology; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Receptors, CCR5 - drug effects; Receptors, CCR5 - physiology; Receptors, CXCR3 - antagonists & inhibitors; Receptors, CXCR3 - drug effects; Receptors, CXCR3 - physiology; Transplantation, Homologous
• ISSN: 1534-6080
• DOI: 10.1097/tp.0b013e31823aa585

The chemokine receptors CCR5 and CXCR3 are expressed by T cells and macrophages. We examined effects of a CCR5/CXCR3 antagonist (TAK), with a particular focus on the role of macrophages, in a rat kidney transplant model. Dark Agouti rat kidneys were transplanted into Lewis rats. The recipients were treated daily with a 10 mg/kg TAK on posttransplant days 0 to 14 and/or 2 mg/kg of cyclosporine A (CsA) on days 0 to 5. Graft survival, histological changes, and the expression of chemokines and chemokine receptors on T cells and macrophages were studied. Treatment with TAK alone suppressed CD4+T cell infiltration and slightly prolonged graft survival. The expressions of both CCR5 and CXCR3, and activated macrophage-associated cytokines and chemokines, were significantly increased on macrophages that had been separated from rejecting kidneys, compared with those from spleens. However, these upregulations were decreased in macrophages from kidneys that had been treated with TAK. Immunohistochemistry also showed that macrophages infiltrating tubules of rejecting kidney expressed both receptors. In the CsA alone group, macrophages were the dominant infiltrating cells, and all allografts were rejected within 10 days. A combined therapy involving CsA and TAK resulted in decreased macrophage infiltration, and graft survival was substantially prolonged. The levels of activated macrophage-associated cytokines and chemokines were also decreased. The dual blocking of CCR5/CXCR3 can be useful in decreasing rejection, with or without CsA. This mechanism acts, not only to block T-cell recruitment to a kidney graft but to suppress the infiltration of macrophages as well.